The Relationship of the in vivo Cell Cycle Characteristics and Treatment Outcome in Acute Myelogenous Leukemia to the Expression of the FMS and MYC Proto-Oncogenes

References

• Raza A., Preisler H. D., Day R., Yasin Z., White L. M., Lykins J., Barcos M., Bennett J., Browman G., Grunwald H., Larson R., Vogler R. Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics. A leukemia intergroup study. Blood 1990; 76(11)2191–2197
   PubMed Web of Science ®Google Scholar
• Preisler H. D., Raza A., Larson R., Le Beau M., Brow-Man G, Goldberg J., Grunwald H., Vogler R., Verkh I., Singh P., Block A. M., Sandberg A. Proto-oncogene expression and the clinical characteristics of acute nonlymphocytic leukemia: A leukemia intergroup pilot study. Blood 1989; 73: 255
   PubMed Web of Science ®Google Scholar
• Preisler H. D., Raza A. Proto oncogene transcript levels and acute nonlymphocytic leukemia. Semin Oncol. 1987; 14(2)207–216
   PubMed Web of Science ®Google Scholar
• Preisler H. D., Raza A., Barcos M., Azarnia N., Larson R., Walker I., Browman M., Grunwald H., D'Arrigo P., Doeblin T., Bloom M., Stein A., Logue G., Goldberg J., Kirshner J., Gottlieb A., Bennett J. High dose cytosine arabinoside as the initial treatment of poor risk patients with acute nonlymphocytic leukemia: A leukemia intergroup study. J. Clin. Oncol. 1987; 5: 75
   PubMed Web of Science ®Google Scholar
• Raza A., Preisler H. D., Li Y. Q., Larson R. A., Goldberg J., Browman G., Bennett J., Grunwald H., Vogler R., Kukla C. Biological characteristics of newly diagnosed poor prognosis acute myelogenous leukemia. Am. J. Hematol. 1993; 42(2)359–365
   PubMed Web of Science ®Google Scholar
• Preisler H. D., Raza A., Early A., Kirshner J., Brecher M., Freeman A., Rustum Y., Azarnia N., Priore R., Sandberg A., Block A. M., Browman G., Walker I., Benjer A., Miller K., D'Arrigo P., Doeblin T., Stein A., Bloom M., Logue G., Rustagi P., Barcos M., Larson R., Joyce R. Intensive remission consolidation therapy in the treatment of acute nonlymphocytic leukemia. J. Clin. Oncol. 1987; 5: 722–730
   PubMed Web of Science ®Google Scholar
• Preisler H. D. Failure of remission induction in acute myelocytic leukemia. Med. Pediatr. Oncol. 1978; 4: 275
   PubMedGoogle Scholar
• Preisler H. D. Evaluation of in vitro predictive assays for acute myelocytic leukemia. Blut 1980; 41: 393
   PubMedGoogle Scholar
• Preisler H. D. Treatment failure in AML. Blood Cells 1982; 8: 585
   PubMedGoogle Scholar
• Preisler H. D., Kinniburgh A., Guan W., Khan S. Expression of the proto-oncogenes C-MYC, C-FOS, and C-FMS in acute myelocytic leukemia at diagnosis and remission. Cancer Res. 1987; 47(3)874
   PubMed Web of Science ®Google Scholar
• Raza A., Maheshwari Y., Preisler H. D. Differences in cell cycle characteristics amongst patients with acute nonlymphocytic leukemia. Blood 1987; 69(6)1647
   PubMed Web of Science ®Google Scholar
• Raza A., Preisler H. D. Evidence of in vivo differentiation in myeloblast labeled with bromodeoxyuridine. J. Cancer 1986; 1(1)15–18
   Google Scholar
• Preisler H. D., Raza A., Azarnia N., Rakowski I., Barcos M., Browman G., Goldberg J., Gottlieb A. Changes in the characteristics of the bone marrow during therapy for acute nonlymphocytic leukemia: Relationship to response to remission induction therapy. Eur. J. Cancer Clin. Oncol. 1985; 21(5)563
   PubMedGoogle Scholar
• Rambaldi A., Wakamiya N., Vellenga E., Horiguchi J., Warren M. K., Kufe D., Griffin J. D. Expression of the macrophage colony-stimulating factor and C-FMS genes in human acute myeloblasts leukemia cells. J. Clin. Invest. 1988; 81: 1020
   PubMed Web of Science ®Google Scholar
• Ashman R. A., Look A. T., Roberts W. M., Roussel M. F., Seremetis S., Ohtsuka M., Sherr C. J. Monoclonal antibodies to the human CSF-1 receptor detect epitopes on normal mononuclear phagocytes and on human myeloid leukemic blast cells. Blood 1989; 73: 827
   PubMed Web of Science ®Google Scholar
• Tamura T., Brost H., Kabrish A., Lampert F., Hadurger-Fangmeirer A., Niemann H. Detection of FMS-oncogene-specific tyrosine kinase activity in human leukemia cells. J. Cancer Res. Clin. Oncol. 1989; 115: 235
   PubMed Web of Science ®Google Scholar
• Raza A., Preisler H. D., Lampkin B. C., Yousuf N., Tucker C., Peters N., White L. M., Kukla C., Gartside P., Siegrist C., Bismayer J., Barcos M., Bennett J., Browman G., Goldberg J., Grunwald H., Larson R., Vardiman J., Vogler R. Biologic significance of cell cycle kinetics in 128 standard risk newly diagnosed patients with acute myelocytic leukemia. Br. J. Haematol. 1990; 75: 340–345
   PubMed Web of Science ®Google Scholar
• Raza A., Abbas A., Yousuf N., Lampkin B., Bennett J., Browman G., Goldberg J., Grunwald H., Larson R., Vogler R., Preisler H. D. Comparison of cell cycle characteristics and their prognostic value in 234 newly diagnosed patients with acute myelocytic leukemia who had “Standard Risk” or “High Risk” disease. Proc. American Society of Hematology 33rd Annual Meeting. Blood 1991; 78(10)422a, Abstract No. 1679
   Google Scholar
• Raza A., Miller M. A., Mazewski C., Sheikh Y., Lampkin B., Saway R., Crone K., Berger T., Reising J., Gray J., Khan S., Preisler H. Observations regarding DNA replication sites in human cells in vivo following infusions of iododeoxyuridine and bromodeoxyuridine. Cell Proliferation 1991; 24: 113
   PubMed Web of Science ®Google Scholar
• Coppola J. A., Cole M. D. Constitutive C-MYC oncogene expression blocks mouse erythroleukemia cell differentiation but not commitment. Nature 1986; 320: 760
   PubMed Web of Science ®Google Scholar
• Dmitrovsky E., Kuelis W., Hollis G., Kirsch I., Bender T., Segal S. Expression of a transfected human C-MYC oncogene inhibits differentiation of a mouse erythroleukemia cell line. Nature (London) 1986; 322: 748
   PubMed Web of Science ®Google Scholar
• Freytag S. O. Enforced expression of the C-MYC oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state G0/G1. Mol. Cell Biol. 1988; 8: 1614
   PubMed Web of Science ®Google Scholar
• Gopal V., Hulete B., Li Y. Q., Kuvelkar R., Raza A., Larson R., Goldberg J., Trist G., Bennett J., Preisler H. D. Myc and Myb expression in acute myelogenous leukemia. Leuk. Res. 1992; 10: 1003–1011
   Web of Science ®Google Scholar
• Espinoza-Delgado I., Longo D. L., Gusella G. L., Varesio L. IL2 enhances C-FMS expression in human monocytes. J. Immunol. 1990; 145: 1137
   PubMed Web of Science ®Google Scholar